Omeros Corporation (OMER)
|52 Week Range||0.92-7.8|
|1y Target Est||-|
|DCF Unlevered||OMER DCF ->|
|DCF Levered||OMER LDCF ->|
|Debt / Equity||-2443.19%||Strong Sell|
Upgrades & Downgrades
Latest OMER news
Omeros: Why It Is Worthwhile To Bet On Narsoplimab
27 November 2023
Omeros Corporation focuses on small-molecule and antibody drugs for common disorders and rare diseases. The company has prioritized the resubmission of its BLA for Narsoplimab for TA-TMA treatment and...
Omeros to terminate kidney disease trial as therapy fails late-stage study
16 October 2023
Omeros Corp said on Monday it will discontinue a trial studying its therapy to treat a type of kidney disease after it failed to meet the main goal of the late-stage study.
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
4 August 2023
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended June 30, 2023, on Wednesday, August 9, 2023, before...
Omeros Corporation - Still Looking Too Risky For A Buy Rating
21 July 2023
Omeros Corporation's share price has seen significant run-ups in recent months despite disappointing first quarter results in 2023 and the company's lack of profitability. The company was awarded $6.6...
Omeros Announces Webcast Details for Annual Meeting of Shareholders
21 June 2023
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER), today announced that the company will host a live webcast of its Annual Meeting of Shareholders, which will be held virtually on Friday, Ju...
Why Shares of Omeros Dropped on Monday
12 June 2023
The company's lead therapy, Narsoplimab, has not yet been approved. As of the first quarter, Omeros had $371.4 million in cash.
Omeros Corporation (OMER) Q1 2023 Earnings Call Transcript
9 May 2023
Omeros Corporation (NASDAQ:OMER ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Jennifer Williams - Investor Relations Greg Demopulos - Chairman and CEO Mike Jacobsen - C...
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023
4 May 2023
SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2023, on Tuesday, May 9, 202...
Omeros Corporation (OMER) Q4 2022 Earnings Call Transcript
13 March 2023
Omeros Corporation (NASDAQ:OMER ) Q4 2022 Earnings Conference Call March 13, 2023 4:30 PM ET Company Participants Jennifer Williams - Investor Relations Dr. Greg Demopulos - Chairman and CEO Mike Jaco...